Jump to main content
Jump to site search

Issue 11, 2011
Previous Article Next Article

Epigenetic modulation of human breast cancer by metallofullerenol nanoparticles: in vivo treatment and in vitro analysis

Author affiliations

Abstract

Multi-hydroxylated endohedral metallofullerenol [Gd@C82(OH)22]n nanoparticles possess the general physico-chemical characteristics of most nanoparticles. They also exhibit uniquely low toxicity and antineoplastic efficacy. In the current study, the molecular mechanisms and epigenetic characteristics of the antineoplastic action of these nanoparticles are explored. Human breast cancer MCF-7 and human umbilical vein endothelial ECV304 cell lines were used. Cell viability assay, cell hierarchical cluster analysis by cDNA microarray, semi-quantitative reverse transcription-polymerase chain reaction and Western blot analysis were conducted to investigate the changes in molecular and cellular signaling pathways caused by [Gd@C82(OH)22]n. The results demonstrated the high antitumor activity and low cytotoxicity of [Gd@C82(OH)22]n nanoparticles both in vivo and in vitro. Their possible anti-tumor mechanisms were also discussed. The present study may provide new insight into the mechanism of action of these nanoparticles.

Graphical abstract: Epigenetic modulation of human breast cancer by metallofullerenol nanoparticles: in vivo treatment and in vitro analysis

Back to tab navigation

Article information


Submitted
21 Jul 2011
Accepted
03 Sep 2011
First published
04 Oct 2011

Nanoscale, 2011,3, 4713-4719
Article type
Paper

Epigenetic modulation of human breast cancer by metallofullerenol nanoparticles: in vivo treatment and in vitro analysis

J. Meng, J. Xing, Y. Wang, J. Lu, Y. Zhao, X. Gao, P. C. Wang, L. Jia and X. Liang, Nanoscale, 2011, 3, 4713
DOI: 10.1039/C1NR10898K

Social activity

Search articles by author

Spotlight

Advertisements